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The diagnosis of Parkinson’s disease (PD) remains still clinical; nevertheless, in the last
decades, the rapid evolution of advanced MRI techniques has made it possible to detect
structural and, increasingly, functional brain changes in patients with PD. Indeed, functional
MRI (fMRI) techniques have offered the opportunity to directly measure the brain’s activity
and connectivity in patients with PD both in early and complicated stage of the disease.The
aims of the following review are (1) to present an overview of recent fMRI reports inves-
tigating the activity and connectivity of sensorimotor areas in patients with PD using both
task-related and “resting-state” fMRI analysis (2) to elucidate potential pathophysiological
mechanisms underlying dyskinetic motor complications in the advanced stage of PD.
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INTRODUCTION
Parkinson’s disease (PD), the second most common neurode-
generative disease worldwide, is characterized by bradykinesia
and at least one of tremor, rigidity, and postural instability (1).
Although recent advances in neuroimaging have provided new
insights into the pathophysiology of the disease, the diagnosis
of PD remains still clinical, based upon the presence of cardi-
nal motor symptoms (2). Neuroimaging of PD has been histor-
ically dominated by positron emission tomography (PET) and
single-photon emission computed tomography (SPECT) studies
using a variety of dopaminergic radiopharmaceuticals that focus
on striatal measures of nigrostriatal neurons (3). Concurrently,
fluorodeoxyglucose–PET has been used to image abnormal covari-
ance patterns of cortical and subcortical regional metabolism that
correlate with motor and cognitive impairment (4). On the other
hand, conventional brain MRI is currently limited to the differ-
ential diagnosis between idiopathic PD and atypical or secondary
parkinsonism or to prognosticate, and to locate the targets for
functional neurosurgery (5). However, the use of 7-T MRI scan-
ners has recently allowed to detect anatomical changes in nigral
morphology in PD, which may represent, in the near future, a
reliable MRI biomarker of PD diagnosis (6, 7). Nevertheless, in
the last decades, the rapid evolution of advanced MRI techniques
has allowed us to further investigate the progression of nigral and
extra-nigral degeneration with greatly improved spatial resolution
and a minimal invasiveness. Moreover, functional MRI (fMRI)
techniques have offered the possibility to directly measure the
brain’s activity and connectivity in patients with PD both in early
and complicated stage of the disease. Therefore, morphological
and fMRI techniques may shed lights on pathophysiological
mechanisms of PD and its disease and treatment-related complica-
tions. The most commonly used method, among fMRI techniques,
is the measurement of blood oxygen level dependent (BOLD) sig-
nal, based on the differences between magnetic characteristics of
oxyhemoglobin (diamagnetic) and deoxyhemoglobin (paramag-
netic). In the brain, neuronal activity increases consistently with
blood flow and oxyhemoglobin and could be hence visualized
by changes in the BOLD contrast. This neuroimaging technique
enables to explore brain function and connectivity with high tem-
poral and spatial resolution (8). More recently, fMRI in the absence
of experimental tasks and behavioral responses, performed with
the patient in a relaxed “resting” state (RS-fMRI), has allowed for
the exploration of brain connectivity between functionally linked
cortical regions (9), the so-called resting-state networks (RSNs).
The most commonly reported RSNs are the default mode network,
the fronto-parietal network, and the sensorimotor network (9),
which is crucial for the execution of voluntary movements and
functionally connects regions within the supplementary motor
area (SMA) and the primary motor cortex (M1) (10, 11). The
aims of the following review are (1) to present an overview of
recent fMRI reports, which have investigated, in patients with PD,
the activity and connectivity of the sensorimotor areas using both
task-related and “resting-state” fMRI analysis, respectively, (2)
to elucidate potential pathophysiological mechanisms underlying
motor complications in the advanced stage of PD.
TASK-RELATED fMRI STUDIES
In the last decades, fMRI studies, employing motor tasks requiring
motor selection and initiation (12–14), have consistently shown
an abnormal activation of different areas of the motor network
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in patients with early and late-stage PD. The integrity of this net-
work is required not only to perform a voluntary movement but
also for readiness for a future motor task. These functional changes
have been correlated both to bradykinesia and to the severity of
the disease (i.e., Hoehn and Yahr stage). Specifically, these studies
have commonly revealed hypoactivation of the SMA, and hyper-
activation of cerebellum and other cortical motor regions, such
as premotor (PMC), primary motor (M1), and parietal cortices
in patients with PD compared to age-related healthy controls. It
is noteworthy that these results have shown striking similarity
with the pattern of altered cerebral metabolic activity observed
with PET in patients with PD (15–18). Levodopa or apomor-
phine administration (12, 19), ventral posterolateral pallidotomy
(20), or deep brain stimulation of the subthalamic nucleus (STN)
(21) can relatively normalize the reduced activation of the SMA,
and decrease the overactivation of other cortical regions. Because
the SMA contributes to the preparation and execution of learned
motor sequences (22–24), its decreased activation may be an
important factor contributing to the lack of readiness and to the
difficulty in initiating voluntary movements in patients with PD.
Moreover, the hyperactivation of cortico-cerebellar regions may
reflect a functional compensation for the defective basal ganglia in
motor control. In other words, patients with PD may need com-
pensatory activity of other motor circuits to overcome their diffi-
culty in performing self-initiated movements (25). The compen-
sation operated by the cerebellum could be achieved through the
cerebello-thalamo-cortical loop or more directly through direct
projections from the cerebellum to the basal ganglia (26, 27). Yu
and colleagues (27) have found a significant negative correlation
between the BOLD response in the putamen and the contralateral
cerebellum, confirming cerebellar compensatory role in patients
with PD. On the other hand, no significant correlation between
the putamen and M1 was found and M1 hyperactivation was pos-
itively correlated only with the severity of upper limb rigidity.
The increased connectivity between the M1 and pre-SMA has not
only a compensatory role but could also reflect primary patho-
physiological changes of PD, as a consequence of the inability to
inhibit contextually inappropriate circuits (21, 28). Although sev-
eral imaging studies on PD have reported similar findings (13, 19,
29), Buhmann and colleagues (19) have observed, in “drug-naïve”
patients with PD while performing a simple, auditory-paced ran-
dom finger-opposition task, a reduced activation of M1, which
was partially restored only after levodopa intake. Thus, it is possi-
ble that the strengthened connectivity of the M1 and the related
compensatory functional reorganization may be induced by the
prolonged dopaminergic treatment. Functional reorganization of
M1, indeed, is absent in“drug-naïve”patients with PD and hypoac-
tivation of this brain region reflects the decreased input arising
from the subcortical motor loop, which is partially restored by
dopaminergic treatment.
RESTING-STATE fMRI STUDIES
The interpretation of these functional changes may be confounded
by the fact that patients with PD have difficulty with performing
motor tasks. RS-fMRI can overcome this problem by providing
an index of connectivity across the whole brain. For this rea-
son, a number of studies have applied RS-fMRI technique to
investigate sensorimotor network connectivity in patients with PD
(30–37). These reports have commonly demonstrated a disrupted
functional integration in corticostriatal loops. Wu and colleagues
(36), using a regional homogeneity approach, have demonstrated
a decreased functional connectivity in the SMA, left dorsal lat-
eral prefrontal cortex (DLPFC), and putamen and an increased
cerebellar connectivity in patients with PD without dopaminer-
gic medication for at least 12 h (“off-state”). The decreased SMA
and basal ganglia connectivity was negatively correlated with the
unified Parkinson’s disease rating scale (UPDRS) score, whereas
a positive correlation was identified between increased cerebel-
lar connectivity and the UPDRS score. Thus, this suggests that
as the disorder progresses, resting-state neuronal activity in the
SMA and basal ganglia becomes more abnormal and, at the mean
time, the compensatory effect in the cerebellum is more signifi-
cant. Previous fMRI and PET reports (19, 29, 38, 39) have already
highlighted the involvement of DLPFC in patients with PD. The
decreased connectivity of this region is probably related to the
reduction in the attention to action and in performance monitor-
ing typically observed in patients with PD. In another connectivity
study by the same group (37), an increased connectivity in the
right M1 and a decreased connectivity in the left putamen were
confirmed in patients with PD. Moreover, an inferior parietal lob-
ule (iPL) and a PMC disconnection with the pre-SMA were also
detected. Thus, greater PD-related connectivity changes occur in
networks linked to preparation and initiation rather than in those
involved in motor execution. Indeed, iPL and PMC are related
to the integration between motor selection and external informa-
tion and selection of movements into a precise plan, respectively
(22, 40, 41). The increased resting-state connectivity between the
pre-SMA and right M1 confirms the potential compensation for
the described decreased motor network connectivity in PD. In
the first placebo-controlled RS-fMRI study, exploring the intrin-
sic sensorimotor network functional connectivity in “drug-naïve”
patients with PD (42), we have demonstrated a decreased regional
connectivity in the SMA in the “off-state,” which was partially
restored only after levodopa administration. Moreover, a region
of interest (ROI) analysis of the sensorimotor network functional
connectivity in the basal ganglia and thalamus revealed that lev-
odopa significantly increased the participation of these subcortical
regions to the sensorimotor network activity. Finally, no statis-
tically significant differences were detected between the groups
in the M1 connectivity, confirming that the compensatory func-
tional reorganization may be related to prolonged dopaminergic
treatment rather than PD per se. Dopaminergic modulation of
resting-state functional connectivity in “drug-naïve” patients with
PD has also been evaluated using a correlation analysis with
dopamine levels in the striatum, assessed quantitatively by FP-
CIT PET (43). Choosing four ROIs, posterior cingulate cortex
(PCC), putamen (anterior and posterior), and caudate, the authors
found that the DLPC was the primary dopamine-dependent cor-
tical region that was functionally connected with the anterior and
posterior putamen. Moreover, patterns of dopamine-dependent
positive functional connectivity varied depending on the loca-
tion of the striatal seeds; dopamine-dependent functional con-
nectivity from the caudate predominantly overlaid pericentral
cortical areas, whereas dopamine-dependent structures that were
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functionally connected to the posterior putamen predominantly
involved cerebellar areas. Finally, there were cortical areas where
the cortico-cortical or striato-cortical connectivity were negatively
associated with the dopaminergic status in the posterior puta-
men. Therefore, dopamine deficiency may lead to alterations in
resting-state functional connectivity and reorganization of striato-
cortical functional network in patients with PD. This may be one
of mechanisms underlying impaired sensorimotor integration in
PD. According to Braak staging (44), the pathologic process of PD,
occurring primarily in the brainstem, pursues an ascending course
reaching the neocortex in the final stage; thus, subcortical involve-
ment prevails throughout the course of PD and functional changes
in the basal ganglia lie at the heart of PD. Based on this a number of
seed based RS-fMRI studies (31, 32, 45), using left and right puta-
men, caudate, and amygdala as seeds, have shown a significantly
reduced connectivity within mesolimbic–striatal and corticostri-
atal loops in “drug-naïve” PD patients. In these studies, both
anterior and posterior putamen showed a decreased connectivity
pattern with their contralateral putamen and mesolimbic regions,
especially in amygdala, hippocampus, olfactory area, and posterior
rectus, whereas the posterior putamen presented a more promi-
nent decreased pattern extending to sensorimotor cortex. The
caudate connectivity pattern was relatively spared. Functional con-
nectivity analysis of the amygdala also showed coherent reduced
connectivity pattern with the putamen. Moreover, putamen con-
nectivity with amygdala, a limbic region crucial for emotional
processing (45) was significantly correlated with non-motor symp-
tom scale (NMSS) total score and NMSS mood subscale score.
No compensatory increased functional connectivity was found in
this study. Baudrexel and colleagues (30) set out to define the
differences of resting-state STN functional connectivity networks
between patients suffering from early stage PD and healthy con-
trols using this straightforward seed-region approach. STN was
selected as seed region because it is both part of the slow “indirect”
and a fast “hyper-direct” functional cortico-subcortical loop, and
it is currently the most effective target for DBS in patients suffering
from advanced PD (46). The analysis revealed an increased func-
tional connectivity between right and left STN and bilateral M1,
PMC, SMA, and also primary sensory regions in patients with PD,
confirming the well-established results from electrophysiological
recordings, which have demonstrated excessive synchronization
in basal ganglia-cortical circuitries at a vastly different temporal
scale (47–49). This fMRI resting-state study provides an addi-
tional evidence that a pathologic subthalamic–cortical coupling
might be a crucial factor in the pathophysiology of PD (50). These
results are in line with the original model of BG functioning pro-
posed by Alexander and DeLong (51, 52); dopamine depletion,
indeed, causes suppression of the “direct” cortical-BG feedback
loop (cortex–striatum–internal globus pallidum/SNr–thalamus–
cortex) and a release of the “indirect” loop (cortex–striatum–
external globus pallidum–STN–GPi/SNr–thalamus–cortex) both,
resulting in hyperactivity of the STN. Although RS-fMRI studies
have mainly provided insights into the pathophysiological mecha-
nisms underlying motor and non-motor symptoms of PD, a recent
study (53) has demonstrated that changes in basal ganglia network
(BGN) connectivity could help us to differentiate patients with
PD from healthy controls. Using a BGN template derived from
80 elderly controls, patients with PD showed a reduced functional
connectivity in a wide range of BGN areas (such as putamen,
caudate, anterior thalamus, DLPC, and precuneus). This func-
tional alteration was clearly improved by levodopa administration.
Moreover, average BGN connectivity was able to differentiate
patients with PD from controls with 100% sensitivity and 89.5%
specificity, confirming the potential role of RS-fMRI connectivity
as a biomarker in early PD.
SENSORIMOTOR CONNECTIVITY IN DYSKINETIC PHASE
Long-term levodopa treatment is complicated by the gradual
development of involuntary movements referred to as levodopa-
induced dyskinesias (LID). Recent studies have evidenced a sub-
stantial progress in understanding the cellular and molecular
mechanisms, which underlie dyskinesias (54, 55). Hypersensitivity
of striatal medium spiny neurons to pulsatile dopamine recep-
tor stimulation during task-related corticostriatal activation of
glutamate receptors seem to plays a crucial role to the develop-
ment of these motor complications (56). Neuroimaging studies
of dyskinesias in humans are sparse, because dyskinesias cause
movement artifacts impairing data quality. Cerasa and colleagues
(57), comparing patients with PD with and without LID dur-
ing execution of externally and internally triggered visuomotor
tasks, showed significant SMA hyperactivity and hypoactivity in
the right inferior prefrontal gyrus only in patients with LID. How-
ever, it remains unclear how intake of levodopa modulates neural
activity in patients with dyskinesias. More recently, Herz and col-
leagues (58) performed a task-related fMRI experiment in the time
window between the intake of levodopa and the onset of motor
complication in dyskinetic vs. non-dyskinetic patients with PD,
which were asked to produce a mouse click with the right or left
hand or no action (No-Go). During No-Go trials, patients with
PD, who would later develop dyskinesias, showed an abnormal
gradual increase of activity in the pre-SMA and the bilateral puta-
men during the first 20 min after levodopa intake. This rapidly
emerging hypersensitivity of putamen and pre-SMA in the con-
text of movement suppression (No-Go) and in the pre-dyskinesia
period might reflect an unphysiological facilitation or impaired
inhibition, via striatal D2-type receptors (56), of motor programs,
resulting in aberrant activity in interconnected cortical areas.
CONCLUSION
In conclusion, although the diagnosis of PD remains still clinical,
functional imaging studies can provide great insights into connec-
tivity changes and pathogenic processes in PD. Task-related fMRI
studies have shown an abnormal activation of different areas of
the motor network in patients with early and late-stage PD related
to cardinal clinical features. More recently, RS-fMRI techniques
have been used to investigate sensorimotor network connectivity
in patients with PD confirming a disrupted functional integration
in corticostriatal loops. Therefore, in the near future, the practical
application of these techniques may provide a better understand-
ing of disease- and treatment-related complications and a reliable
MRI biomarker for an early diagnosis of PD.
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